Cormorant Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.33M | Sell |
|
|||||
|
2024
Q3 | $19.1M | Hold |
|
|||||
|
2024
Q2 | $17.5M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $732K | Hold |
|
|||||
|
2022
Q3 | $2.16M | Hold |
|
|||||
|
2022
Q2 | $2.27M | Hold |
|
|||||
|
2022
Q1 | $1.78M | Sell |
|
|||||
|
2021
Q4 | $4.86M | Sell |
|
|||||
|
2021
Q3 | $14.3M | Sell |
|
|||||
|
2021
Q2 | $27M | Sell |
|
|||||
|
2021
Q1 | $37.2M | Sell |
|
|||||
|
2020
Q4 | $82.3M | Buy |
|
|||||
|
2020
Q3 | $53.7M | Sell |
|
|||||
|
2020
Q2 | $68M | Sell |
|
|||||
|
2020
Q1 | $45.2M | Buy |
|
|||||
|
2019
Q4 | $50.1M | Buy |
|
|||||
|
2019
Q3 | $23M | Sell |
|
|||||
|
2019
Q2 | $22.9M | Buy |
|
|||||
|
2019
Q1 | $18.8M | Buy |
|
|||||
|
2018
Q4 | $3.96M | Sell |
|
|||||
|
2018
Q3 | $5.31M | Buy |
|